Dupixent 300 MG/2 ML pen 2ML
Ended Awarded
- Contract number
- SPE2DB25FFGZ5
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $65,102
Award facts
- Contract value 100% obligated
- $65,101.62 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $65,101.62 to AmerisourceBergen Drug Corp for the supply of Dupixent 300 mg/2 ml pen auto-injectors on September 4, 2025, with completion scheduled for September 5, 2025. This firm fixed-price delivery order was awarded competitively with no set-aside designation and will be fulfilled from the vendor's facility in Conshohocken, Pennsylvania. Dupixent (dupilumab) is a prescription biologic medication used to treat moderate-to-severe atopic dermatitis, moderate-to-severe asthma, and other inflammatory conditions, representing a significant pharmaceutical commodity within the Defense Health System's medical supply requirements.
This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at approximately $1 billion and extends through December 2026. As a child contract under this comprehensive pharmaceutical prime vendor agreement, the delivery order enables AmerisourceBergen to continue its role as a critical supplier of specialty medications and medical supplies to military healthcare programs globally. The vendor's extensive portfolio of federal contract awards demonstrates its established capability to meet specialized pharmaceutical procurement requirements across the Defense Health Agency and other federal healthcare systems through competitive delivery orders with firm fixed pricing.
Quick answers
Who was awarded contract SPE2DB25FFGZ5?
SPE2DB25FFGZ5 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 4, 2025.
How much is contract SPE2DB25FFGZ5 worth?
The government has obligated $65,102 on SPE2DB25FFGZ5.
Is contract SPE2DB25FFGZ5 an order under another contract?
Yes. SPE2DB25FFGZ5 is a delivery order under SPE2DB22D1106, an indefinite delivery contract.
Was contract SPE2DB25FFGZ5 competed?
The extent of competition for SPE2DB25FFGZ5 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award